These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Discovery of N-{N-[(3-cyanophenyl)sulfonyl]-4(R)-cyclobutylamino-(L)-prolyl}-4-[(3',5'-dichloroisonicotinoyl) amino]-(L)-phenylalanine (MK-0668), an extremely potent and orally active antagonist of very late antigen-4. Lin LS; Lanza T; Jewell JP; Liu P; Jones C; Kieczykowski GR; Treonze K; Si Q; Manior S; Koo G; Tong X; Wang J; Schuelke A; Pivnichny J; Wang R; Raab C; Vincent S; Davies P; Maccoss M; Mumford RA; Hagmann WK J Med Chem; 2009 Jun; 52(11):3449-52. PubMed ID: 19441819 [TBL] [Abstract][Full Text] [Related]
50. New GABA-modulating 1,2,4-oxadiazole derivatives and their anticonvulsant activity. Lankau HJ; Unverferth K; Grunwald C; Hartenhauer H; Heinecke K; Bernöster K; Dost R; Egerland U; Rundfeldt C Eur J Med Chem; 2007 Jun; 42(6):873-9. PubMed ID: 17303289 [TBL] [Abstract][Full Text] [Related]
51. Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists. Cheng Y; Albrecht BK; Brown J; Buchanan JL; Buckner WH; DiMauro EF; Emkey R; Fremeau RT; Harmange JC; Hoffman BJ; Huang L; Huang M; Lee JH; Lin FF; Martin MW; Nguyen HQ; Patel VF; Tomlinson SA; White RD; Xia X; Hitchcock SA J Med Chem; 2008 Aug; 51(16):5019-34. PubMed ID: 18680277 [TBL] [Abstract][Full Text] [Related]
52. Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a. Skinner PJ; Cherrier MC; Webb PJ; Shin YJ; Gharbaoui T; Lindstrom A; Hong V; Tamura SY; Dang HT; Pride CC; Chen R; Richman JG; Connolly DT; Semple G Bioorg Med Chem Lett; 2007 Oct; 17(20):5620-3. PubMed ID: 17804224 [TBL] [Abstract][Full Text] [Related]
53. Synthesis and SAR of alpha-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors. Zhang YM; Fan X; Xiang B; Chakravarty D; Scannevin R; Burke S; Karnachi P; Rhodes K; Jackson P Bioorg Med Chem Lett; 2006 Jun; 16(12):3096-100. PubMed ID: 16632358 [TBL] [Abstract][Full Text] [Related]
54. Ligand binding of leukocyte integrin very late antigen-4 involves exposure of sulfhydryl groups and is subject to redox modulation. Liu SY; Tsai MY; Chuang KP; Huang YF; Shieh CC Eur J Immunol; 2008 Feb; 38(2):410-23. PubMed ID: 18196516 [TBL] [Abstract][Full Text] [Related]
55. Synthesis and structure-activity relationships of C-glycosylated oxadiazoles as inhibitors of glycogen phosphorylase. Tóth M; Kun S; Bokor E; Benltifa M; Tallec G; Vidal S; Docsa T; Gergely P; Somsák L; Praly JP Bioorg Med Chem; 2009 Jul; 17(13):4773-85. PubMed ID: 19450985 [TBL] [Abstract][Full Text] [Related]
56. Investigation of the teratogenic potential of VLA-4 antagonist derivatives in rats. Sakurai K; Matsuoka T; Suzuki C; Kinoshita J; Takayama G; Shimomura K Reprod Toxicol; 2014 Nov; 49():162-70. PubMed ID: 25194688 [TBL] [Abstract][Full Text] [Related]
57. Identification of unique VLA-4 antagonists from a combinatorial library. de Laszlo SE; Li B; McCauley E; Van Riper G; Hagmann WK Bioorg Med Chem Lett; 2002 Feb; 12(4):685-8. PubMed ID: 11844701 [TBL] [Abstract][Full Text] [Related]
58. Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors. Rydzewski RM; Burrill L; Mendonca R; Palmer JT; Rice M; Tahilramani R; Bass KE; Leung L; Gjerstad E; Janc JW; Pan L J Med Chem; 2006 May; 49(10):2953-68. PubMed ID: 16686537 [TBL] [Abstract][Full Text] [Related]
59. The identification and optimization of orally efficacious, small molecule VLA-4 antagonists. Huryn DM; Konradi AW; Ashwell S; Freedman SB; Lombardo LJ; Pleiss MA; Thorsett ED; Yednock T; Kennedy JD Curr Top Med Chem; 2004; 4(14):1473-84. PubMed ID: 15544538 [TBL] [Abstract][Full Text] [Related]
60. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles. Kumar D; Patel G; Johnson EO; Shah K Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]